Condition

Type2diabetes

ClinicalTrials.gov condition label

Clinical trials74

Recruiting22

Common interventions25

Lead sponsors shown15

Clinical trials

60 shown

Feasibility and Adherence to a Technology-assisted Home-based Strength Training Program in Adults With Type 2 Diabetes Mellitus and Mild Cognitive ImpairmentNCT07416799 · 2026-04-14

Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart FailureNCT06364644 · 2025-06-20

Type 2 Diabetes and Blood Brain Barrier ImprovementNCT06322212 · 2024-08-01

Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and CoachingNCT05662462 · 2024-07-11

The Impact of Geriatric Assessment on the Treatment Plan of Elderly Patients With T2DMNCT06469437 · 2024-07-05

DM Treatment to Evaluate the Efficacy and Safety of Dapagliflozin or Pioglitazone in Patients with Type 2 DiabetesNCT06875193 · 2024-05-28

Fiber Supplementation in Heart Failure With Preserved Ejection Fraction (HFpEF)NCT06337812 · 2024-04-01

Depletion of Liver Fat in Type 2 DiabetesNCT06211556 · 2024-02-01

Real Time Continuous Glucose Monitoring System in T2DM With PregnacyNCT05947916 · 2024-01-30

Ketones, SGLT2, HFrEFNCT06229678 · 2024-01-25

Susceptibility to Infectious Diseases in obEsity: an endocRine trAnslational socioLogic Evaluation, "SIDERALE"NCT06236932 · 2023-12-29

SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With PrediabetesNCT06054035 · 2023-10-26

Promoting Alternatives to Sulfonylureas to Improve Patient Safety in Type 2 DiabetesNCT05933174 · 2023-10-01

Susceptibility to Infectious Diseases in ObesityNCT05975541 · 2023-10-01

Comorbidities Resolution After MGB Surgery and Change in Body CompositionNCT06015620 · 2023-09-01

A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARENCT05909046 · 2023-07-24

The CARING Study: Creating and Restoring Health Through Nutrition GuidanceNCT05795439 · 2023-07-11

NAD Augmentation in Diabetes Kidney DiseaseNCT05759468 · 2023-04-13

The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric RestrictionNCT05499702 · 2022-12-15

Assessment of Pancreatic Beta Cell Mass and Function by Positron Emission Tomography Imaging in Human Diabetes MellitusNCT05662189 · 2022-03-15

Mitochondrial Substrate Utilization in the Diabetic Human HeartNCT05958706 · 2021-12-01

Metabolic Effects of Bariatric Arterial Embolization vs Bariatric SurgeryNCT05859022 · 2021-06-16

CGM Experience, Preferences & Blood Glucose ParametersNCT07607015 · 2026-09-10

NOT_YET_RECRUITING

Continued Access to the Endogenex System for Participants in the ReCET Pivotal StudyNCT07197788 · 2026-09-01

ENROLLING_BY_INVITATION

Use of taVNS for Painful Diabetic Neuropathy: 12-Week Randomized, Sham-Controlled TrialNCT06292962 · 2025-01-05

Assessment of Safety, Tolerability and Drug Levels of Exenatide ImplantNCT05670379 · 2024-12-20

Comparison of the Safety, Efficacy and Pharmacokinetics of DehydraTECH -CBD and DehydraTECH-GLP1 Agonists Alone or in Combination, in Overweight or Obese, Pre- and Type 2 Diabetic ParticipantsNCT06648031 · 2024-12-04

Effects of High-Intensity Interval Training and Quinoa Supplementation in Women With Type 2 DiabetesNCT07863934 · 2024-10-16

Motivational Interviewing Applied to Individuals With DiabetesNCT06345196 · 2024-10-15

(DDS) in India: a Screening Tool to Identify Prediabetes and Undiagnosed Type 2 Diabetes in Dental SettingsNCT06453278 · 2024-09-01

Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in BangladeshNCT06449235 · 2024-09-01

Exercise Training and Type 2 DiabetesNCT06478173 · 2024-08-01

Evaluation of Fuling Yunhua Granules and Dihuang Baoyuan Granules in Drug Naive Type 2 Diabetes PatientsNCT06575478 · 2024-07-31

Nutrition Outreach and Understanding: Research In Serving Hearts Through Healthy Eating And Tailored SupportNCT06460272 · 2024-07-30

The Effects of Upper Extremity Aerobic Exercise Training in Patients With Type 2 DiabetesNCT06132334 · 2024-05-20

Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II DiabetesNCT06267391 · 2024-05-01

ACTIVE_NOT_RECRUITING

The Bennett Kids PowerUP ProjectNCT05858580 · 2024-03-01

Liom Non-invasive Continuous Glucose Monitor "Clinical Demo" (niCGM)NCT06272136 · 2024-02-23

The CanDo (Canadian Donor Milk) TrialNCT06315127 · 2024-02-06

ACTIVE_NOT_RECRUITING

Combining Gene Variants to Improve Risk Prediction for Metabolic (Dysfunction)- Associated Fatty Liver Disease and Its Progression to Cirrhosis in Indian Individuals With Type 2 DiabetesNCT06289387 · 2024-01-20

A Study of Biochemical Response to Alternative ProteinsNCT06253728 · 2024-01-18

A Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 DiabetesNCT06263348 · 2024-01-17

Factors of Control Hypertension or Type 2 Diabetes on the Severity of Stroke and Survival Rates Within 1 Year in TratNCT06288269 · 2023-11-01

Effect of Short-term Basal Insulin Initiation in Newly Diagnosed Type 2 Diabetes on 1-year Glycemic ControlNCT06107153 · 2023-11-01

Postural Control, Ankle and Trunk Proprioception in Type 2 DiabetesNCT06045598 · 2023-09-10

Physical Activity and CVD in Adolescents With Type 2 DiabetesNCT05724888 · 2023-09-01

Characteristics of Blood Glucose Variability in Patients With Type 2 Diabetes Mellitus and COVID-19NCT06156137 · 2023-08-01

EFFECT SGLT2 INHIBITORS ON CONTRAST MEDIUM INDUCED ACUTE KIDNEY INJURYNCT06288529 · 2023-07-15

Use of AI in Cardiometabolic Risk Prediction in Asian IndiansNCT05939869 · 2023-07-01

The PIVOT Trial: Project on EHR-Integrated Lifestyle Interventions for Adults Aged Fifty and OlderNCT05654142 · 2023-04-17

ACTIVE_NOT_RECRUITING

Effect of a Pharmacist-led, Collaborative Practice on Clinical Outcomes in Persons with DiabetesNCT05995262 · 2023-04-06

A Trial to Evaluate the Effect of C21 on Endothelial Dysfunction in Subjects With Type 2 DiabetesNCT05831644 · 2023-03-31

Preoperative Carbohydrate Loading in Diabetes MellitusNCT07237841 · 2023-03-01

Combination of Henagliflozin and Continuous Subcutaneous Insulin Infusion in T2DMNCT05677334 · 2023-03-01

ARIADNE: A Study of Weight Loss for Diabetes Treatment and WellbeingNCT05744232 · 2023-03-01

FreeStyle Libre Monitoring in T2DMNCT05597293 · 2023-02-27

N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP) in Type 2 Diabetes MellitusNCT05745090 · 2022-11-10

ACTIVE_NOT_RECRUITING

Effect of Metformin, Dapagliflozin, Combination of Metformin and Pioglitazone in Patients With Type 2 DiabetesNCT05591235 · 2022-11-01

The Effects of Glucagon on Hepatic MetabolismNCT05500586 · 2022-10-20

Evaluation of Lifestyle Modification on Cardiovascular RiskNCT05417698 · 2022-08-15

ACTIVE_NOT_RECRUITING

Common interventions

MetforminDRUG3 control groupOTHER2 DapagliflozinDRUG2 PlaceboDRUG2 25% Carbohydrate solution (CHO drinking)DIETARY_SUPPLEMENT1 68Ga-exendin-4DRUG1 Acipimox 250 Mg Oral CapsuleDRUG1 Alpha-Glucosidase InhibitorDRUG1 Arm 1 - DehydraTECH-CBD aloneDRUG1 Arm 2 - DehydraTECH-semaglutide aloneDRUG1 Arm 3 - DehydraTECH-CBD in combination with DehydraTECH-semaglutideDRUG1 Arm 4 - Rybelsus medication (semaglutide) aloneDRUG1 Arm 5- TirzepatideDRUG1 Augmented InterventionBEHAVIORAL1 Bariatric Arterial Embolization (BAE) procedureOTHER1 Base interventionBEHAVIORAL1 Bennett Kids PowerUP ProjectBEHAVIORAL1 Bydureon BCise (exenatide extended release)DRUG1 C21DRUG1 Caloric RestrictionBEHAVIORAL1 Care team coaching for medical and social needs (HUB)BEHAVIORAL1 CGMDEVICE1 Chart ReviewOTHER1 Clinical Demo 2.0DEVICE1 Combined high-intensity interval training and quinoa consumptionCOMBINATION_PRODUCT1

Leading sponsors

Diabetes Foundation, India3 Adrian Vella2 Endogenex, Inc.2 Medanta, The Medicity, India2 Ohio State University2 All India Institute of Medical Sciences, Bhubaneswar1 Amanda Shallcross1 Ayurai Private Limited1 Azienda Ospedaliero Universitaria Maggiore della Carita1 Azienda Ospedaliero-Universitaria di Parma1 Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders1 Beijing Supreme Life Pharmaceutical Technology Co., Ltd.1 Bozok University1 Brigham and Women's Hospital1 Copenhagen University Hospital, Rigshospitalet1

Trial status mix

COMPLETED29

RECRUITING22

UNKNOWN15

ACTIVE_NOT_RECRUITING6

ENROLLING_BY_INVITATION1

NOT_YET_RECRUITING1

Phase mix

NA39

PHASE46

PHASE14

PHASE24

EARLY_PHASE12

PHASE32

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.